Age-related macular degeneration (ARMD) is the most important cause of visual impairment in the elderly, affecting 14 million patients in the US alone. ARMD is manifested as two forms: dry ARMD, characterized by the accumulation of drusen and other deposits under the RPE; and neovascular ARMD, characterized by choroidal neovascularization (CNV), the invasion of abnormal new vessels from the subjacent choriocapillaris. Macrophages, major effector cells of innate immunity, are observed in the choriocapillaris underlying areas of thick deposits and within CNV. We propose that these macrophages are blood-derived monocytes recruited to the choriocapillaris in response to deposit accumulation. Although their pathogenic contribution in ARMD remains unknown, our long term goal is to establish that macrophages are disease response modifiers that are either beneficial or harmful depending upon their pre-existing activation state. The current proposal will continue studies to support the hypothesis that partially activated macrophages are associated with ARMD progression, especially CNV, and to refine the definition of partially activated macrophages in terms of expression of various mediators relevant to ARMD pathogenesis. A new focus will be to test the hypothesis that chronic infection of monocytes with cytomegalovirus is one cause for the development of partially-activated monocytes in some ARMD patients.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY013318-07
Application #
7497459
Study Section
Biology and Diseases of the Posterior Eye Study Section (BDPE)
Program Officer
Shen, Grace L
Project Start
2001-02-01
Project End
2010-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
7
Fiscal Year
2008
Total Cost
$375,066
Indirect Cost
Name
Duke University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Marin-Castano, Maria E; Csaky, Karl G; Cousins, Scott W (2005) Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity. Invest Ophthalmol Vis Sci 46:3331-40
Espinosa-Heidmann, Diego G; Marin-Castano, Maria E; Pereira-Simon, Simone et al. (2005) Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. Exp Eye Res 80:413-23
Caicedo, Alejandro; Espinosa-Heidmann, Diego G; Hamasaki, Duco et al. (2005) Photoreceptor synapses degenerate early in experimental choroidal neovascularization. J Comp Neurol 483:263-77
Espinosa-Heidmann, Diego G; Reinoso, Maria A; Pina, Yolanda et al. (2005) Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization. Exp Eye Res 80:369-78
Caicedo, Alejandro; Espinosa-Heidmann, Diego G; Pina, Yolanda et al. (2005) Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp Eye Res 81:38-47
Suner, Ivan J; Espinosa-Heidmann, Diego G; Marin-Castano, Maria E et al. (2004) Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 45:311-7
Miller, Daniel M; Espinosa-Heidmann, Diego G; Legra, Jessica et al. (2004) The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol 138:323-8
Cousins, Scott W; Espinosa-Heidmann, Diego G; Csaky, Karl G (2004) Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol 122:1013-8
Espinosa-Heidmann, Diego G; Sall, John; Hernandez, Eleut P et al. (2004) Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E. Invest Ophthalmol Vis Sci 45:260-6
Espinosa-Heidmann, Diego G; Suner, Ivan J; Hernandez, Eleut P et al. (2003) Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3586-92

Showing the most recent 10 out of 13 publications